Efficacy and security of continent catheterizable channels at short and middle term for adult neurogenic bladder dysfunction

Prog Urol. 2019 Dec;29(17):1047-1053. doi: 10.1016/j.purol.2019.08.278. Epub 2019 Sep 17.

Abstract

Aims: The objective of this study was to assess the effectiveness and the complications rate following continent cutaneous channels (CCC) procedures, at short and medium term follow-up (FU).

Materials & methods: A continuous retrospective case series (2008-2018): all patients who have undergone a CCC for neurogenic bladder were included in our department. The primary outcome was the effectiveness of CCC defined by the status of catheterizability (by the patient or a care-giver), continence of the tube, and absence of reintervention at 3 and 12 months FU. The secondary outcome was the prevalence of postoperative complications at 3 and 12 months FU.

Results: Fifty-three patients were included during the study period in our department. Median follow up was 3,3 years (1.5-6.1). The overall effectiveness of CCC was 67.9% (n=36/53) at 3 months FU and 45,3% (n=24) at 12 months FU. The global rate of complications was 60.4% (n=32/53) at 3 months, and 73.6% (n=39/73) at 12 months FU. The statistical analysis showed no statistical differences on efficacy and complications in the different subgroups of CCC.

Conclusions: In the current series, the effectiveness and the complications rates following CCC were comparable across the procedure types.

Level of evidence: 4.

Keywords: Complications; Cystostomie; Efficacité; Functional efficacity; Intermittent catheterization; Neurogenic bladder; Sondage intermittent; Urinary diversion; Vessie neurologique.

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder, Neurogenic / surgery*
  • Urinary Catheterization* / adverse effects
  • Urinary Reservoirs, Continent* / adverse effects